257 related articles for article (PubMed ID: 34830233)
1. A Hypothetical Model Suggesting Some Possible Ways That the Progesterone Receptor May Be Involved in Cancer Proliferation.
Check JH; Check DL
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830233
[TBL] [Abstract][Full Text] [Related]
2. Therapy Aimed to Suppress the Production of the Immunosuppressive Protein Progesterone Induced Blocking Factor (PIBF) May Provide Palliation and/or Increased Longevity for Patients With a Variety of Different Advanced Cancers - A Review.
Check JH; Check D
Anticancer Res; 2019 Jul; 39(7):3365-3372. PubMed ID: 31262857
[TBL] [Abstract][Full Text] [Related]
3. New Insights as to Why Progesterone Receptor Modulators, such as Mifepristone, Seem to Be More Effective in Treating Cancers that Are Devoid of the Classical Nuclear Progesterone Receptor.
Check JH; Check D
Anticancer Res; 2021 Dec; 41(12):5873-5880. PubMed ID: 34848442
[TBL] [Abstract][Full Text] [Related]
4. Evidence that progesterone receptor antagonists may help in the treatment of a variety of cancers by locally suppressing natural killer cell activity.
Check JH; Sansoucie L; Chern J; Amadi N; Srivastava M; Larece K
Clin Exp Obstet Gynecol; 2007; 34(4):207-11. PubMed ID: 18225679
[TBL] [Abstract][Full Text] [Related]
5. Expression and modulation of progesterone induced blocking factor (PIBF) and innate immune factors in human leukemia cell lines by progesterone and mifepristone.
Srivastava MD; Thomas A; Srivastava BI; Check JH
Leuk Lymphoma; 2007 Aug; 48(8):1610-7. PubMed ID: 17701593
[TBL] [Abstract][Full Text] [Related]
6. The progesterone receptor antagonist mifepristone does not lower serum progesterone induced blocking factor (PIBF) in the presence of progesterone.
Check JH; DiAntonio G; DiAntonio A; Duroseau M
Clin Exp Obstet Gynecol; 2016; 43(2):189-91. PubMed ID: 27132407
[TBL] [Abstract][Full Text] [Related]
7. Support for the hypothesis that successful immunotherapy of various cancers can be achieved by inhibiting a progesterone associated immunomodulatory protein.
Check JH; Dix E; Sansoucie L
Med Hypotheses; 2009 Jan; 72(1):87-90. PubMed ID: 18842348
[TBL] [Abstract][Full Text] [Related]
8. The interplay between intracellular progesterone receptor and PKC plays a key role in migration and invasion of human glioblastoma cells.
Marquina-Sánchez B; González-Jorge J; Hansberg-Pastor V; Wegman-Ostrosky T; Baranda-Ávila N; Mejía-Pérez S; Camacho-Arroyo I; González-Arenas A
J Steroid Biochem Mol Biol; 2017 Sep; 172():198-206. PubMed ID: 27717886
[TBL] [Abstract][Full Text] [Related]
9. Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma.
Altinoz MA; Ozpinar A; Elmaci I
Neurosurg Rev; 2019 Jun; 42(2):351-369. PubMed ID: 29453736
[TBL] [Abstract][Full Text] [Related]
10. Progesterone-induced blocking factor is hormonally regulated in human astrocytoma cells, and increases their growth through the IL-4R/JAK1/STAT6 pathway.
González-Arenas A; Valadez-Cosmes P; Jiménez-Arellano C; López-Sánchez M; Camacho-Arroyo I
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():463-70. PubMed ID: 25218441
[TBL] [Abstract][Full Text] [Related]
11. The antiabortive effect of progesterone-induced blocking factor in mice is manifested by modulating NK activity.
Szekeres-Bartho J; Par G; Dombay Gy; Smart YC; Volgyi Z
Cell Immunol; 1997 May; 177(2):194-9. PubMed ID: 9178647
[TBL] [Abstract][Full Text] [Related]
12. Progesterone Decreases in vitro Indoleamine 2, 3-dioxygenase Expression in Dendritic and CD4
Bianchi PKFDC; Leandro RM; Poscai AN; Yoshinaga T; Gonçalez PO; Kfoury Junior JR
Immunol Invest; 2017 Jul; 46(5):447-459. PubMed ID: 28414589
[TBL] [Abstract][Full Text] [Related]
13. Effect of early pregnancy on the expression of progesterone receptor and progesterone-induced blocking factor in ovine lymph node.
Yang L; Zang S; Bai Y; Yao X; Zhang L
Theriogenology; 2017 Apr; 93():78-83. PubMed ID: 28257871
[TBL] [Abstract][Full Text] [Related]
14. The Role of Extracellular Vesicles and PIBF in Embryo-Maternal Immune-Interactions.
Szekeres-Bartho J; Šućurović S; Mulac-Jeričević B
Front Immunol; 2018; 9():2890. PubMed ID: 30619262
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and immunologic characterization of a novel cDNA coding for progesterone-induced blocking factor.
Polgar B; Kispal G; Lachmann M; Paar C; Nagy E; Csere P; Miko E; Szereday L; Varga P; Szekeres-Bartho J
J Immunol; 2003 Dec; 171(11):5956-63. PubMed ID: 14634107
[TBL] [Abstract][Full Text] [Related]
16. PIBF (progesterone induced blocking factor) is overexpressed in highly proliferating cells and associated with the centrosome.
Lachmann M; Gelbmann D; Kálmán E; Polgár B; Buschle M; Von Gabain A; Szekeres-Barthó J; Nagy E
Int J Cancer; 2004 Oct; 112(1):51-60. PubMed ID: 15305375
[TBL] [Abstract][Full Text] [Related]
17. The role of progesterone and the progesterone receptor in cancer: progress in the last 5 years.
Check JH; Check DL
Expert Rev Endocrinol Metab; 2023 Jan; 18(1):5-18. PubMed ID: 36647582
[TBL] [Abstract][Full Text] [Related]
18. Progesterone induced blocking factor isoforms in normal and failed murine pregnancies.
Bogdan A; Polgar B; Szekeres-Bartho J
Am J Reprod Immunol; 2014 Feb; 71(2):131-6. PubMed ID: 24325791
[TBL] [Abstract][Full Text] [Related]
19. Changes in expression of ISG15, progesterone receptor and progesterone-induced blocking factor in ovine thymus during early pregnancy.
Zhang L; Xue J; Wang Q; Lv W; Mi H; Liu Y; Yang L
Theriogenology; 2018 Nov; 121():153-159. PubMed ID: 30149261
[TBL] [Abstract][Full Text] [Related]
20. Mifepristone treatment improves length and quality of survival of mice with spontaneous leukemia.
Check JH; Sansoucie L; Chern J; Amadi N; Katz Y
Anticancer Res; 2009 Aug; 29(8):2977-80. PubMed ID: 19661303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
